These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 5700590)

  • 1. [Use of sordinol in mental disordes of vascular origin].
    Romanova IS; Banshchikov VM; Rozhanets RV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1223-8. PubMed ID: 5700590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
    Poeldinger W
    Arzneimittelforschung; 1967 Sep; 17(9):1133-5. PubMed ID: 5632287
    [No Abstract]   [Full Text] [Related]  

  • 3. [The relationship between the affect of perplexity, manifestations of preoccuption and the type of disease].
    Belen'kaia NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):876-80. PubMed ID: 4471594
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies with oxypertine in chronically psychotic patients].
    Eckmann F; Badalik L
    Arzneimittelforschung; 1970 Feb; 20(2):268-9. PubMed ID: 5467473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of diazepam in psychiatric practice].
    Aleksandrovskiĭ IuA; Prokudin VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1231-7. PubMed ID: 5705720
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychopharmacological treatment of disorders of senescence.
    Fann WE; Wheless JC; Richman BW
    N C Med J; 1974 Nov; 35(11):672-7. PubMed ID: 4530160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenic factors and the anatomic basis of vascular psychoses].
    Kushelev VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(7):1032-7. PubMed ID: 4544281
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of the clinico-pathophysiologic characteristics of psychoses in old age under the influence of azafen].
    Taranskaia AD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):440-3. PubMed ID: 1266520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
    Voina S
    Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
    [No Abstract]   [Full Text] [Related]  

  • 10. [Manifestations of atherosclerosis of the cerebral vessels and their relation to mental changes in patients with a history of myocardial infarct].
    Beliakova NA; Slezkina LA
    Klin Med (Mosk); 1984 Nov; 62(11):70-4. PubMed ID: 6521382
    [No Abstract]   [Full Text] [Related]  

  • 11. [Side effects of methylperone in long-term therapy up to 8 years].
    Kirkegaard G; Kirkegaard A
    Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency].
    Digo R; Bellot JC
    Encephale; 1969; 58(3):267-82. PubMed ID: 5378185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurophysiologic changes in the brain in atherosclerotic psychoses (a morphometric study)].
    Turgiev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):241-6. PubMed ID: 123401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebrovascular disorders and symptoms of psychotic disorders].
    Efuku T
    Nihon Ishikai Zasshi; 1970 Feb; 63(4):621-4. PubMed ID: 5462872
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical responses to Cinnarizin in various psychiatric syndromes.
    Szobor A; Klein M
    Ther Hung; 1973; 21(1):31-4. PubMed ID: 4792889
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Encephabol in patients with organic brain-syndrome.
    Haskovec L; Jirsák R; Srutová K
    Act Nerv Super (Praha); 1974; 16(4):259-60. PubMed ID: 4451004
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the therapeutic effect of sordinol and fluanxol in the treatment of schizophrenic patients].
    Kontsevoi VA; Panteleeva GP; Zavidovskaia GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1238-43. PubMed ID: 5370166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical picture of hallucinatory-paranoid psychoses in cerebral atherosclerosis].
    Turgiev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(3):421-6. PubMed ID: 645322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of luliberin in the treatment of mental disorders in cerebral arteriosclerosis].
    Tikhomirov SM; Bakharev VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):121-3. PubMed ID: 2158710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of cerebro-organic changes due to age with kavaform].
    Kurz JF
    Landarzt; 1968 Aug; 44(23):iv-xii. PubMed ID: 4883272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.